SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/BEB3060C2A224A7D15FB5430247FD694E86DDAEDDFA2BDC817AEBB94F4F5B343E0E376F940C3947DCE48999ECEA41970>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/BEB3060C2A224A7D15FB5430247FD694E86DDAEDDFA2BDC817AEBB94F4F5B343E0E376F940C3947DCE48999ECEA41970
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/BEB3060C2A224A7D15FB5430247FD694E86DDAEDDFA2BDC817AEBB94F4F5B343E0E376F940C3947DCE48999ECEA41970
http://www.w3.org/2000/01/rdf-schema#comment
"Data demonstrate that the CB2 receptor is a potential target for the treatment of SSc because it controls both skin fibroblast proliferation and the autoimmune reaction."
xsd:string
http://purl.uniprot.org/uniprot/#_86BB532B0CF397B6D73607507278A4032DEFFF0F45791869C706DE9D193B400C02C1530F8830286D7A64331B284B091A
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/BEB3060C2A224A7D15FB5430247FD694E86DDAEDDFA2BDC817AEBB94F4F5B343E0E376F940C3947DCE48999ECEA41970
http://purl.uniprot.org/uniprot/P47936
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/BEB3060C2A224A7D15FB5430247FD694E86DDAEDDFA2BDC817AEBB94F4F5B343E0E376F940C3947DCE48999ECEA41970
http://purl.uniprot.org/uniprot/#_P47936-mappedCitation-20508030
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/BEB3060C2A224A7D15FB5430247FD694E86DDAEDDFA2BDC817AEBB94F4F5B343E0E376F940C3947DCE48999ECEA41970